LIVE Ventures.

Venture Capital / Academic Incubationduke-nus.edu.sg

LIVE Ventures is a venture incubation programme of Duke-NUS Medical School in Singapore that catalyses commercialisation of academic research. Its documented activity is co-investment in Duke-NUS spin-outs such as Brano Therapeutics.

Company typePrivate
Founded-
HeadquartersSingapore, Singapore
Headcount—
GTM typeB2B
OfferingServices

What LIVE Ventures. does

LIVE Ventures is an incubation programme associated with Duke-NUS Medical School in Singapore, structured to catalyse the commercialisation of innovative academic research originating from the institution's research programmes and spin-offs. Its functional role is that of a venture and incubation entity — sourcing, funding, and supporting early-stage companies that translate Duke-NUS research into commercial products.

The only documented capital activity in the available source material is LIVE Ventures' participation as a financial investor in a US$6.8 million seed funding round for Brano Therapeutics (announced 2026-05-07), a Duke-NUS biotechnology spin-off developing novel treatments for heart failure, including Heart Failure with preserved Ejection Fraction (HFpEF). The round was led by Trinity Innovation Bioventure Singapore and SEEDS, with additional participation from SGInnovate, placing LIVE Ventures in a co-investor role rather than as lead.

The source data does not disclose a separate legal incorporation, fund size, ticket sizes, headcount, management team, portfolio composition, revenue model, pricing, or product offerings for LIVE Ventures as a standalone entity. Its operating geography is Singapore, with activity concentrated in Southeast Asia. As a programme embedded within an academic institution, its economic model is most plausibly tied to institutional funding rather than market-generated revenue, though this is not directly confirmed in the available material.

LIVE Ventures. firmographics

Firmographics

Name: LIVE Ventures.
Legal name: LIVE Ventures
Website: https://duke-nus.edu.sg
Company type: Private
Operating status: Operating
Short description: LIVE Ventures is a venture incubation programme of Duke-NUS Medical School in Singapore that catalyses commercialisation of academic research. Its documented activity is co-investment in Duke-NUS spin-outs such as Brano Therapeutics.
Ownership category
akta.pro rank

LIVE Ventures. industry classification

Industry

Product category: Venture Capital / Academic Incubation
NAICS: Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)
SIC: Investment Advice (6282)
akta.pro primary industry: Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)
akta.pro secondary industry: Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

Academic research commercialisation
Seed venture funding
Life sciences incubation
Biotech spin-off investment
Academic venture capital

Where LIVE Ventures. is headquartered

Location

Headquarters

HQ city: Singapore
HQ country: Singapore
HQ region: Asia

Markets served

LIVE Ventures. business model

Business model

GTM type: B2B
Offering type: Services

LIVE Ventures. product offering

Product offering

Core offering

LIVE Ventures is an incubation programme under Duke-NUS Medical School that invests seed capital into academic spin-off companies to commercialise innovative biomedical research. Its sole documented activity is participation as a financial investor in Brano Therapeutics' US$6.8 million seed funding round in 2026, alongside Trinity Innovation Bioventure Singapore, SEEDS, and SGInnovate.

Product overview

Based on the available source data, LIVE Ventures is a venture investment entity associated with Duke-NUS Medical School in Singapore. The source data provides limited information about LIVE Ventures' specific products or services. The only documented activity is LIVE Ventures' participation as an investor in Brano Therapeutics' US$6.8 million seed funding round (2026). No detailed product portfolio, service offerings, or technology products are described for LIVE Ventures in the source material.

Differentiator

Problem solved

Functional benefit

Products and services

LIVE Ventures Incubation Programme

Companies that use LIVE Ventures.

Customer profile

Ideal customer profiles1 record

LIVE Ventures. technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

LIVE Ventures. partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights2 records

LIVE Ventures. competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

LIVE Ventures. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LIVE Ventures. leadership team

Management profile

Number of profiles

LIVE Ventures. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LIVE Ventures. M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIVE Ventures.

What does LIVE Ventures. do?

Is LIVE Ventures. a public or private company?

LIVE Ventures. is a private company. It is classified as corporate owned and is currently operating.

When was LIVE Ventures. founded?

LIVE Ventures. was founded in -1.

Where is LIVE Ventures. based?

LIVE Ventures. is headquartered in Singapore, Singapore, in the Asia region.

Does LIVE Ventures. have an API?

No public API is recorded for LIVE Ventures..

What industry is LIVE Ventures. in?

LIVE Ventures.'s product category is Venture Capital / Academic Incubation. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 523940 and its SIC code is 6282.